Topics

Diagnostic BioSystems Company Profile

05:49 EST 17th November 2019 | BioPortfolio

Since its inception in 1994, DBS has been committed to supplying highest quality products to its customers. We have got a rapid customer’s acceptance because of our highest quality products. We want to thank all our customers and collaborators for their constant support. Our business philosophy is “Customer First.” In this catalog, we are offering you the highest quality pre-optimized primary antibodies in three different sizes to allow labs performing manual staining as well as automated systems, more choices and flexibility. This year we are offering you expanded range of concentrated as well as pretitered primary antibodies. Besides universal detection system kits, we are offering you individual kit components. At DBS, we are continuously working on to provide you the cutting edge products/reagents. To complement that, we are offering you the following unique antibodies and related products for immunohistochemistry in this catalog;

Location

1020 Serpentine Ln.Suite # 114
Pleasanton
California
94566
United States of America

Contact

Phone: 925-484-3350
Fax: 925-484-3390
Email: bipin@dbiosys.com


News Articles [456 Associated News Articles listed on BioPortfolio]

T2 Biosystems Expands Rapid Diagnostic Technologies to Australia, Fiji and New Zealand

T2 Biosystems (NASDAQ:TTOO) has announced it has expanded its diagnostic technologies, including T2Bacteria and T2Candida Panels, to Australia, Fiji and New Zealand. As quoted in the press release:  ...

T2 Biosystems to enter 5 new markets

T2 Biosystems will launch its rapid diagnostic tests in Estonia, Greece, Ireland, Saudi Arabia and South Africa after enterin -More- 

Microbix Biosystems Q-2 2019 revenue shows impressive numbers with big gains

Microbix Biosystems (TSE:MBX) CEO Cameron Groome joined Steve Darling from Proactive Investors Vancouver to discuss one of the leading manufacturers of viral and bacterial products used in the manuf...

T2 Biosystems’ T2Resistance™ Panel is First Diagnostic to Graduate from CARB-X Portfolio

LEXINGTON, Mass., Sept. 24, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization of innovative medical diagnostic products for critica...

T2 Biosystems Expands Global Access to its Innovative Rapid Diagnostic Technologies

LEXINGTON, Mass., July 26, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announc...

T2 Biosystems Expands Access to its Innovative Rapid Diagnostic Technologies to Australia, Fiji and New Zealand

LEXINGTON, Mass., Aug. 16, 2019 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development of innovative diagnostic products for critical unmet needs in healthcare, announc...

T2 Biosystems to Expand into Puerto Rico and US Virgin Islands

The company will expand its rapid diagnostic technologies such as T2Bacteria and T2Candida Panels into Puerto Rico and the US Virgin Islands. The post T2 Biosystems to Expand into Puerto Rico and US ...

T2 Biosystems Highlights Current and Future Opportunities for its Breakthrough Rapid Diagnostic Technology for Biothreat Pathogen Detection

Data on T2Candida auris research-use-only demonstrates 5-hour time-to-resultversus 14-days with blood culture T2MR Technology demonstrates high sensitivity for the detection of biothreat pathogen...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Xenon, xe-133 [curium us llc]

Xenon Xe 133 GasRx only Diagnostic

PubMed Articles [1107 Associated PubMed Articles listed on BioPortfolio]

Insights into the effect of different levels of crude oil on hydrolyzed polyacrylamide biotransformation in aerobic and anoxic biosystems: Bioresource production, enzymatic activity, and microbial function.

The differences of crude oil recovery ratio resulted in different levels of crude oil in actual hydrolyzed polyacrylamide (HPAM)-containing wastewater. The effect of crude oil on HPAM biotransformatio...

Performance of the T2Bacteria Panel for Diagnosing Bloodstream Infections: A Diagnostic Accuracy Study.

Blood cultures, the gold standard for diagnosing bloodstream infections (BSIs), are insensitive and limited by prolonged time to results. The T2Bacteria Panel (T2 Biosystems) is a direct-from-blood, n...

Outcomes of patients with non-diagnostic bronchoscopy: A clinico-radiological comparison of patients with diagnostic and non-diagnostic bronchoscopy.

Bronchoscopy is one of the most common diagnostic procedures in pulmonary practice. Data on the outcome of patients following a non-diagnostic bronchoscopy are sparse. Diagnostic yield depends on indi...

Comparison of diagnostic techniques for detection of Giardia duodenalis in dogs and cats.

An evaluation of currently available in-clinic diagnostic tests for Giardia duodenalis infection of dogs and cats has not been performed. In addition, there is discordance among published diagnostic c...

Diagnostic Value of Ultrasound in Detecting Causes of Pediatric Chest X-Ray Opacity.

Computed tomography is considered as the diagnostic gold standard for following up the majority of pediatric chest X-ray (CXR) opacities. However, radiation, cost, and waiting times have led to search...

Clinical Trials [2693 Associated Clinical Trials listed on BioPortfolio]

Circulating microRNAs as Novel Prognosis Biomarkers for Rheumatoid Arthritis

The correlation of circulating serum miR-125ba and miR-146a expression and clinical response to green tea therapy were analysed in RA patients.Clinical response to green tea therapy for 24...

Diagnostic Agreement of iFR and QFR.

A Prospective, observational, single center diagnostic study to investigate the the diagnostic agreement between QFR and the pressure wire-based iFR in a real world setting.

Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism

Diagnostic errors have been reported frequently in patient with pulmonary embolism since symptoms are not specific. However, there is only scarce evidence that the delay associated with di...

Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors

This clinical study is designed to evaluate the diagnostic performance of VisioCyt test, which would improve the early diagnosis of bladder cancer in order to optimize the management of in...

A Study to Evaluate Strategies for Teaching Effective Use of Diagnostic Tests

A recent Institute of Medicine monograph brought attention to high rates of diagnostic error and called for better educational efforts to improve diagnostic accuracy.1 Educational methods,...

Companies [1140 Associated Companies listed on BioPortfolio]

Diagnostic BioSystems, Inc.

Diagnostic BioSystems, Inc. is a well respected company providing a complete line of products for the pathology laboratory performing Immunohistochemistry tests, and other advance...

Akonni BioSystems

Akonni Biosystems, is a molecular diagnostics (MDx) company that develops, manufactures, and markets integrated molecular diagnostic systems. All of Akonni Biosystems tests are currently for Research...

Seventh Sense Biosystems, Inc.

Seventh Sense Biosystems is an early stage, private company developing a new generation of blood access and diagnostic products that promise unprecedented convenience and simplici...

Kapa Biosystems

Kapa Biosystems is a next-generation life science reagents supplier that employs high-throughput molecular evolution to optimize enzymes for DNA amplification, next-generation DNA...

Kapa Biosystems, Inc.

Kapa Biosystems is a life science reagents supplier that employs proprietary, directed evolution technologies to optimize enzymes for PCR, real-time PCR, next generation sequencin...

More Information about "Diagnostic BioSystems" on BioPortfolio

We have published hundreds of Diagnostic BioSystems news stories on BioPortfolio along with dozens of Diagnostic BioSystems Clinical Trials and PubMed Articles about Diagnostic BioSystems for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Diagnostic BioSystems Companies in our database. You can also find out about relevant Diagnostic BioSystems Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record